← back to search

Jamal Benhamida

Memorial Sloan Kettering Cancer Center · US
Area of research
Cancer Research · Genetics
Research interest
Research interests include Cancer Genomics and Diagnostics, Glioma Diagnosis and Treatment, Sarcoma Diagnosis and Treatment, and Pancreatic and Hepatic Oncology Research.
h-index
22
citations
2,347
works
141
NIH funding
primary concept
email

Recent publications

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification
Cancer Cell 2025cited by 14position: middledoi
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant
Neuro-Oncology 2025cited by 12position: middledoi
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification
medRxiv 2025cited by 5position: middledoi
Advancing sarcoma diagnostics with expanded DNA methylation-based classification
medRxiv 2025cited by 3position: middledoi
Mucinous cystic neoplasms of the pancreas and liver share a similar <scp>DNA</scp> methylation profile with mucinous ovarian tumors
The Journal of Pathology 2025cited by 2position: middledoi
SWI/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis
Modern Pathology 2024cited by 17position: middledoi
DNA Methylation Profiling Enables Accurate Classification of Nonductal Primary Pancreatic Neoplasms
Clinical Gastroenterology and Hepatology 2024cited by 13position: middledoi
DNA methylation classifier to diagnose pancreatic ductal adenocarcinoma metastases from different anatomical sites
Clinical Epigenetics 2024cited by 3position: middledoi
Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
Nature Communications 2023cited by 49position: middledoi
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
Nature Communications 2023cited by 27position: middledoi
Distinct IDH1/2-associated Methylation Profile and Enrichment of <i>TP53</i> and <i>TERT</i> Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma
Cancer Research Communications 2023cited by 19position: middledoi
Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in pediatric, adolescent and young adult brain tumor patients
Neuro-Oncology 2022cited by 92position: middledoi
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma
Neuro-Oncology 2022cited by 62position: middledoi
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics
Neuro-Oncology 2022cited by 30position: middledoi
Sarcoma classification by DNA methylation profiling
Nature Communications 2021cited by 536position: middledoi
Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature
Modern Pathology 2021cited by 44position: middledoi
Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions
Acta Neuropathologica Communications 2020cited by 50position: middledoi
Malignant transformation of a polymorphous low grade neuroepithelial tumor of the young (PLNTY)
Acta Neuropathologica 2020cited by 49position: middledoi
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions
Cancer Research 2019cited by 180position: middledoi
Sclerosing epithelioid mesenchymal neoplasm of the pancreas – a proposed new entity
Modern Pathology 2019cited by 16position: middledoi
Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution
Cancer Cell 2018cited by 224position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marc Ladanyi · Center for Cancer Research5 papers (2019–2023) · 4 papers (2019–2023)David S. Klimstra · Marmara University3 papers (2024–2025)Marc K. Rosenblum · Cornell University3 papers (2020–2022)Christopher Neumann · Humboldt-Universität zu Berlin2 papers (2024–2025)David Horst · German Cancer Research Center2 papers (2024–2025)Olca Baştürk · Cornell University2 papers (2024–2024)Ryma Benayed · AstraZeneca (United States)2 papers (2019–2020)Martin Sill · German Cancer Research Center2 papers (2020–2020) · 2 papers (2024–2025)Elena Grafenhorst · German Cancer Research Center2 papers (2024–2025)Matthias A. Karajannis · New York Proton Center2 papers (2020–2022)George A. Călin · The University of Texas MD Anderson Cancer Center2 papers (2024–2025)Tejus Bale · NYU Langone Health2 papers (2020–2020)Jaclyn F. Hechtman · NeoGenomics (United States)2 papers (2019–2024)David Capper · German Cancer Research Center2 papers (2024–2025)Tobias Janik · Humboldt-Universität zu Berlin2 papers (2024–2025)Sameer Farouk Sait · Memorial Sloan Kettering Cancer Center2 papers (2020–2022)Simon Schallenberg · German Cancer Research Center2 papers (2024–2025)Baoqing Chen · University of Colorado Denver2 papers (2024–2025)